| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $15.2M | +5.2% |
| SG&A Expense | $7.9M | -18.9% |
| Operating Income | -$23.1M | +4.5% |
| Pre-tax Income | -$29.6M | -115.8% |
| Income Tax | $0 | — |
| Net Income | -$29.6M | -115.8% |
| EPS (Basic) | -$1.97 | -61.5% |
| EPS (Diluted) | -$1.97 | -61.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.5M | +45.2% |
| Short-term Investments | $1.5M | -86.1% |
| Current Assets | $13.5M | -31.2% |
| Total Assets | $13.6M | -31.3% |
| Current Liabilities | $3.8M | +2.7% |
| Total Liabilities | $20.2M | +275.8% |
| Stockholders' Equity | -$6.6M | -146.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.2M | -0.2% |
| Capital Expenditures | $28K | +250.0% |
| Investing Cash Flow | $9.6M | +315.9% |
| Financing Cash Flow | $15.2M | -45.6% |
| Free Cash Flow | -$21.2M | -0.2% |